Ohcanbohtosat - Alessandro Pancrazzi
- Čájehuvvo 1 - 20 / 27
- Sirdás čuovvovaš siidui
-
1
Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients Dahkki Animesh Pardanani, Paola Guglielmelli, Terra L. Lasho, Alessandro Pancrazzi, Christy Finke, Alessandro M. Vannucchi, Ayalew Tefferi
Almmustuhtton 2011Artigo -
2
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis Dahkki Paola Guglielmelli, Giada Rotunno, Tiziana Fanelli, Annalisa Pacilli, G Brogi, Laura Calabresi, Alessandro Pancrazzi, A. M. Vannucchi
Almmustuhtton 2015Carta -
3
-
4
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia Dahkki Giada Rotunno, Carmela Mannarelli, Paola Guglielmelli, Annalisa Pacilli, Alessandro Pancrazzi, Lisa Pieri, Tiziana Fanelli, Alberto Bosi, Alessandro M. Vannucchi
Almmustuhtton 2013Artigo -
5
Anaemia characterises patients with myelofibrosis harbouring <i>Mpl</i><sup><i>W</i>515<i>L</i>/<i>K</i></sup> mutation Dahkki Paola Guglielmelli, Alessandro Pancrazzi, Gaetano Bergamaschi, Vittorio Rosti, Laura Villani, Elisabetta Antonioli, Alberto Bosi, Giovanni Barosi, Alessandro M. Vannucchi
Almmustuhtton 2007Artigo -
6
JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib Dahkki Lisa Pieri, Alessandro Pancrazzi, Annalisa Pacilli, Claudia Rabuzzi, Giada Rotunno, Tiziana Fanelli, Paola Guglielmelli, Rajmonda Fjerza, Chiara Paoli, Srđan Verstovšek, Alessandro M. Vannucchi
Almmustuhtton 2015Carta -
7
Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia Dahkki Elisabetta Antonioli, Paola Guglielmelli, G Poli, Costanza Bogani, Alessandro Pancrazzi, Giovanni Longo, Vanessa Ponziani, Lorenzo Tozzi, Lisa Pieri, Valeria Santini, Alberto Bosi, Alessandro M. Vannucchi
Almmustuhtton 2007Artigo -
8
MicroRNA expression profile in granulocytes from primary myelofibrosis patients Dahkki Paola Guglielmelli, Lorenzo Tozzi, Alessandro Pancrazzi, Costanza Bogani, Elisabetta Antonioli, Vanessa Ponziani, G Poli, Roberta Zini, Sérgio Ferrari, Rossella Manfredini, Alberto Bosi, Alessandro M. Vannucchi
Almmustuhtton 2007Artigo -
9
Elevated monocyte distribution width in COVID-19 patients: The contribution of the novel sepsis indicator Dahkki Agostino Ognibene, Maria Lorubbio, Pasqualino Magliocca, Emanuela Tripodo, Guendalina Vaggelli, Giovanni Iannelli, Marco Feri, Raffaele Scala, Alessandro Polcini Tartaglia, Angelo Galano, Alessandro Pancrazzi, Danilo Tacconi
Almmustuhtton 2020Artigo -
10
Increased Risk of Lymphoid Neoplasms in Patients with Philadelphia Chromosome–Negative Myeloproliferative Neoplasms Dahkki Alessandro M. Vannucchi, Giovanna Masala, Elisabetta Antonioli, Maria Chiara Susini, Paola Guglielmelli, Lisa Pieri, Laura Maggi, Saverio Caini, Domenico Palli, Costanza Bogani, Vanessa Ponziani, Alessandro Pancrazzi, Francesco Annunziato, Alberto Bosi
Almmustuhtton 2009Artigo -
11
A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-β1 in the development of myelofibrosis Dahkki Alessandro M. Vannucchi, Lucia Bianchi, Francesco Paoletti, Alessandro Pancrazzi, Eugenio Torre, Mitsuo Nishikawa, Maria Zingariello, Angela Di Baldassarre, Rosa Alba Rana, R Lorenzini, Elena Alfani, Giovanni Migliaccio, Anna Ritá Migliaccio
Almmustuhtton 2005Artigo -
12
CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients Dahkki Ayalew Tefferi, Paola Guglielmelli, Terra L. Lasho, Giada Rotunno, Christy Finke, C Mannarelli, Alem A. Belachew, Alessandro Pancrazzi, Emnet A Wassie, Rhett P. Ketterling, Curtis A. Hanson, Animesh Pardanani, Alessandro M. Vannucchi
Almmustuhtton 2014Artigo -
13
Molecular Profiling of CD34+ Cells in Idiopathic Myelofibrosis Identifies a Set of Disease-Associated Genes and Reveals the Clinical Significance of Wilms' Tumor Gene 1 (<i>WT1</i>... Dahkki Paola Guglielmelli, Roberta Zini, Costanza Bogani, Simona Salati, Alessandro Pancrazzi, Elisa Bianchi, Francesco Mannelli, Sérgio Ferrari, Marie‐Caroline Le Bousse‐Kerdilès, Alberto Bosi, Giovanni Barosi, Anna Ritá Migliaccio, Rossella Manfredini, Alessandro M. Vannucchi
Almmustuhtton 2006Artigo -
14
Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3 Dahkki Tiziano Barbui, Alessandra Carobbio, Guido Finazzi, Alessandro M. Vannucchi, Giovanni Barosi, Elisabetta Antonioli, Paola Guglielmelli, Alessandro Pancrazzi, Silvia Salmoiraghi, Pio Zilio, Cosimo Ottomano, Roberto Marchioli, Ivan Cuccovillo, Barbara Bottazzi, Alberto Mantovani, Alessandro Rambaldi
Almmustuhtton 2010Artigo -
15
Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele Dahkki Paola Guglielmelli, Giovanni Barosi, Giorgina Specchia, Alessandro Rambaldi, Francesco Lo‐Coco, Elisabetta Antonioli, Lisa Pieri, Alessandro Pancrazzi, Vanessa Ponziani, Federica Delaini, Giovanni Longo, Emanuele Ammatuna, Vincenzo Liso, Alberto Bosi, Tiziano Barbui, Alessandro M. Vannucchi
Almmustuhtton 2009Artigo -
16
Targeted deep sequencing in polycythemia vera and essential thrombocythemia Dahkki Ayalew Tefferi, Terra L. Lasho, Paola Guglielmelli, Christy Finke, Giada Rotunno, Yoseph Elala, Annalisa Pacilli, Curtis A. Hanson, Alessandro Pancrazzi, Rhett P. Ketterling, Carmela Mannarelli, Daniela Barraco, Tiziana Fanelli, Animesh Pardanani, Naseema Gangat, Alessandro M. Vannucchi
Almmustuhtton 2016Artigo -
17
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms Dahkki Elena Tenedini, Isabella Bernardis, Valentina Artusi, Lucia Artuso, Enrica Roncaglia, Paola Guglielmelli, Lisa Pieri, Costanza Bogani, Flavia Biamonte, Giada Rotunno, C Mannarelli, Elisa Bianchi, Alessandro Pancrazzi, Tiziana Fanelli, Guidantonio Malagoli Tagliazucchi, Sérgio Ferrari, Rossella Manfredini, Alessandro M. Vannucchi, Enrico Tagliafico
Almmustuhtton 2013Artigo -
18
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis Dahkki Paola Guglielmelli, Annalisa Pacilli, Giada Rotunno, Elisa Rumi, Vittorio Rosti, Federica Delaini, Margherita Maffioli, Tiziana Fanelli, Alessandro Pancrazzi, Daniela Pietra, Silvia Salmoiraghi, Carmela Mannarelli, Annalisa Franci, Chiara Paoli, Alessandro Rambaldi, Francesco Passamonti, Giovanni Barosi, Tiziano Barbui, Mario Cazzola, Alessandro M. Vannucchi
Almmustuhtton 2017Artigo -
19
Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms Dahkki Elisa Rumi, Daniela Pietra, Paola Guglielmelli, Roberta Bordoni, Ilaria Carola Casetti, Chiara Milanesi, Emanuela Sant’Antonio, Virginia Valeria Ferretti, Alessandro Pancrazzi, Giada Rotunno, Marco Severgnini, Alessandro Pietrelli, Cesare Astori, Elena Fugazza, Cristiana Pascutto, Emanuela Boveri, Francesco Passamonti, Gianluca De Bellis, Alessandro M. Vannucchi, Mario Cazzola
Almmustuhtton 2013Artigo -
20
Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia Dahkki Alessandro M. Vannucchi, Elisabetta Antonioli, Paola Guglielmelli, Alessandro Pancrazzi, Vittoria Guerini, Giovanni Barosi, Marco Ruggeri, Giorgina Specchia, Francesco Lo‐Coco, Federica Delaini, Laura Villani, Silvia Finotto, Emanuele Ammatuna, Renato Alterini, Valentina Carrai, G. Capaccioli, Simonetta Di Lollo, Vincenzo Liso, Alessandro Rambaldi, Alberto Bosi, Tiziano Barbui
Almmustuhtton 2008Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Bone marrow
Myelofibrosis
Biology
Gene
Genetics
Gastroenterology
Immunology
Polycythemia vera
Essential thrombocythemia
Oncology
Mutation
Cancer research
Confidence interval
Gene expression
International Prognostic Scoring System
Myelodysplastic syndromes
Platelet
Anemia
Calreticulin
Endoplasmic reticulum
Haematopoiesis
Leukemia
Molecular biology
Myeloid
Pathology
Phenotype
Proportional hazards model
Stem cell